Quantcast

Latest Metastasis Stories

2014-09-18 23:05:34

Research conducted by a team of neurosurgeons and radiation oncologists from Allegheny Health Network, and presented this week at the American Society for Radiation Oncology annual meeting, has documented improved survival in patients with cancerous brain tumors who undergo both surgical removal of the tumors along with stereotactic radiosurgery. Pittsburgh, PA (PRWEB) September 18, 2014 Research conducted by a team of neurosurgeons and radiation oncologists from Allegheny Health Network...

2014-09-18 12:29:43

The Highest Percentage of Non-Prescribers Anticipate Prescribing Tafinlar and Mekinist Within the Next One to Three Months, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 18, 2014 /PRNewswire/ -- Decision Resources Group finds that at one year post-launch in the United States, 54 percent of surveyed U.S. medical oncologists have prescribed GlaxoSmithKline's BRAF inhibitor Tafinlar for BRAF-mutation-positive unresectable or metastatic melanoma, compared with 49...

2014-09-17 04:20:02

Tokyo, Sept 17, 2014 - (JCN Newswire) - Eisai Co., Ltd. announced today that a series of abstracts highlighting the latest clinical data on Halaven(R) (generic name: eribulin mesylate; non-taxane microtubule dynamics inhibitor, "Halaven") and lenvatinib mesylate (generic name; selective inhibitor of receptor tyrosine kinases (RTKs) with a novel binding mode, "lenvatinib") will be presented during the 39th European Society for Medical Oncology (ESMO) Congress...

2014-09-14 23:00:36

A study led by University of Colorado Cancer Center published today in the journal Nature uses a novel approach to target the activation of a protein that drives some cancers. AURORA, Colo. (PRWEB) September 14, 2014 When active, the protein called Ral can drive tumor growth and metastasis in several human cancers including pancreatic, prostate, lung, colon and bladder. Unfortunately, drugs that block its activity are not available. A study published today in the journal Nature uses a...

2014-09-08 08:31:27

SAN DIEGO and PRINCETON, N.J., Sept. 8, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD), and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), announced today that ESI researchers have developed and initially validated a lectin-based diagnostic platform that is able to isolate exosome-based biomarkers underlying a broad-spectrum of oncology indications. Aethlon Medical develops targeted therapeutic devices to address infectious disease, cancer and other...

2014-09-03 23:05:54

Global research initiative to investigate long-term glioblastoma survivors. Chicago, IL (PRWEB) September 03, 2014 The American Brain Tumor Association (ABTA), in conjunction with the Brain Tumor Funder’s Collaborative (BTFC), is awarding a $2 million research grant to explore commonalities among long-term glioblastoma survivors around the world. Glioblastoma is a common and aggressive type of brain tumor most prevalent in adults ages 45-65, and affects more men than women. This highly...

2014-09-01 16:21:50

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Marketshttps://www.reportbuyer.com/product/2009162/Circulating-Tumor-Cell-CTC-Diagnostics-Technologies-and-Global-Markets.html STUDY GOALS AND OBJECTIVESThis report, PHM153A - Circulating Tumor Cell (CTC) Diagnostic: Technologies and Global Markets, gives market insight on monitoring tests used for cancer prognoses. The...

2014-08-26 23:11:14

Japanese doctors say a technique that measures fluorescent light emissions from cells can be used to help distinguish tiny mesothelioma tumors. Raleigh, NC (PRWEB) August 26, 2014 Cancer researchers in Hokkaido, Japan have successfully used an autofluorescence imaging system to identify mesothelioma and other pleural cancers during video-assisted thoracic surgery. Click here to read Surviving Mesothelioma’s new article on the findings. Scientists at Asahikawa Medical University used a...

2014-08-06 08:31:45

High unmet need addressed with first new approved treatment in eighteen years MISSISSAUGA, ON, August 6, 2014 /CNW/ - Health Canada has approved (Pr)ABRAXANE(®) for Injectable Suspension (paclitaxel powder for injectable suspension) (nanoparticle, albumin-bound [nab(®)] paclitaxel) for first-line treatment of adult patients with metastatic pancreatic cancer. The approval is welcome news for Canadians who are diagnosed with metastatic pancreatic cancer, and represents the first...

2014-07-30 23:07:39

The executive director of the Mesothelioma Applied Research Foundation, Mary Hesdorffer, APRN, was featured as a speaker during a Verastem, Inc. investor meeting to bring attention to mesothelioma and the need for clinical trials to advance and to increase the number therapeutic options for mesothelioma patients. Alexandria, VA (PRWEB) July 30, 2014 On July 10, during the research and development portion of the Verastem, Inc.’s investor meeting, Mary Hesdorffer, APRN, the executive...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'